Okamoto I - Search Results

1

A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801).

Asahina H, Tanaka K, Morita S, Maemondo M, Seike M, Okamoto I, Oizumi S, Kagamu H, Takahashi K, Kikuchi T, Isobe T, Sugio K, Kobayashi K. Asahina H, et al. Among authors: okamoto i. Clin Lung Cancer. 2021 Mar;22(2):147-151. doi: 10.1016/j.cllc.2020.09.023. Epub 2020 Oct 16. Clin Lung Cancer. 2021. PMID: 33199228

2

Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas.

Sasaki JI, Tanabe KK, Takahashi K, Okamoto I, Fujimoto H, Matsumoto M, Suga M, Ando M, Saya H. Sasaki JI, et al. Among authors: okamoto i. Int J Oncol. 1998 Mar;12(3):525-33. doi: 10.3892/ijo.12.3.525. Int J Oncol. 1998. PMID: 9472088

3

The clinical characteristics at the onset of a severe asthma attack and the effects of high frequency jet ventilation for severe asthmatic patients.

Goto E, Okamoto I, Tanaka K. Goto E, et al. Among authors: okamoto i. Eur J Emerg Med. 1998 Dec;5(4):451-5. Eur J Emerg Med. 1998. PMID: 9919451

4

Methotrexate poisoning with acute hepatorenal dysfunction.

Goto E, Tomojiri S, Okamoto I, Tanaka K. Goto E, et al. Among authors: okamoto i. J Toxicol Clin Toxicol. 2001;39(1):101-4. doi: 10.1081/clt-100102887. J Toxicol Clin Toxicol. 2001. PMID: 11327217

5

Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer.

Okamoto I, Fujii K, Matsumoto M, Terasaki Y, Kihara N, Kohrogi H, Suga M. Okamoto I, et al. Lung Cancer. 2003 Jun;40(3):339-42. doi: 10.1016/s0169-5002(03)00043-6. Lung Cancer. 2003. PMID: 12781434

6

Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer.

Araki J, Okamoto I, Suto R, Ichikawa Y, Sasaki J. Araki J, et al. Among authors: okamoto i. Lung Cancer. 2005 Apr;48(1):141-4. doi: 10.1016/j.lungcan.2004.10.012. Epub 2004 Dec 9. Lung Cancer. 2005. PMID: 15777982

7

Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.

Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M. Okamoto I, et al. Jpn J Clin Oncol. 2005 Apr;35(4):188-94. doi: 10.1093/jjco/hyi059. Jpn J Clin Oncol. 2005. PMID: 15845567 Review.

8

Pemetrexed-induced edema of the eyelid.

Kurata T, Tamura K, Okamoto I, Satoh T, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: okamoto i. Lung Cancer. 2006 Nov;54(2):241-2. doi: 10.1016/j.lungcan.2006.08.002. Epub 2006 Sep 22. Lung Cancer. 2006. PMID: 16996165

9

Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification.

Okabe T, Okamoto I, Tamura K, Terashima M, Yoshida T, Satoh T, Takada M, Fukuoka M, Nakagawa K. Okabe T, et al. Among authors: okamoto i. Cancer Res. 2007 Mar 1;67(5):2046-53. doi: 10.1158/0008-5472.CAN-06-3339. Cancer Res. 2007. PMID: 17332333

10

Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer?

Kurata T, Matsuo K, Takada M, Kawahara M, Tsuji M, Matsubara Y, Otani N, Matsuyama S, Muraishi K, Fujita T, Ishikawa M, Koyano K, Okamoto I, Satoh T, Tamura K, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: okamoto i. J Thorac Oncol. 2006 Sep;1(7):684-91. J Thorac Oncol. 2006. PMID: 17409937 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

733 results

Search Page

Filters